To evaluate efficacy & safety of targeted therapy for atopic severe uncontrolled bronchial asthma with various biological products
Latest Information Update: 02 Jul 2020
At a glance
- Drugs Mepolizumab (Primary) ; Omalizumab (Primary) ; Reslizumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 02 Jul 2020 New trial record
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society